Literature DB >> 6293353

Local cellular immunity in tuberculous pleurisy.

K Shimokata, H Kawachi, H Kishimoto, F Maeda, Y Ito.   

Abstract

The characteristics and function of lymphocytes in both pleural exudate and peripheral blood in 18 patients with tuberculous pleurisy were studied. The pleural fluid of 13 of 16 patients with tuberculous pleurisy had more T-lymphocytes than the peripheral blood. The difference between them was significant by the t test (p less than 0.05). When lymphocytes in peripheral blood were cocultured with purified protein derivative (PPD), lymphocytes from only 4 of 18 patients produced immune interferon on the fifth day. The titer was only 4 or 8 units/ml. On the contrary, lymphocytes in pleural fluid from 17 of 18 patients reacted to PPD and produced immune interferon on the fifth day, and titers were much higher (more than 128 units/ml) than those of lymphocytes in peripheral blood. When the relationship between the interferon titer produced by lymphocytes in pleural effusion and tuberculin skin reaction was investigated, the group with the stronger skin reactions showed a significantly higher interferon production (p less than 0.05). In conclusion, exudative-sensitized lymphocytes in morbid sites reacted to the specific antigen more effectively and produced titers of lymphokines than circulating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293353     DOI: 10.1164/arrd.1982.126.5.822

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Interferon gamma for diagnosing tuberculous pleural effusions.

Authors:  S Wongtim; U Silachamroon; K Ruxrungtham; V Udompanich; S Limthongkul; P Charoenlap; C Nuchprayoon
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies.

Authors:  R S Wallis; S L Alde; D V Havlir; M H Amir-Tahmasseb; T M Daniel; J J Ellner
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

3.  Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.

Authors:  S K Sharma; Amit Banga
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

4.  Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to purified protein derivative (PPD).

Authors:  F Lorgat; M M Keraan; S R Ress
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

5.  Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis.

Authors:  T Ogawa; H Uchida; Y Kusumoto; Y Mori; Y Yamamura; S Hamada
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery.

Authors:  G M Ainslie; J A Solomon; E D Bateman
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

7.  Combining ADA, protein and IFN-gamma best allows discrimination between tuberculous and malignant pleural effusion.

Authors:  Y C Kim; K O Park; H S Bom; S C Lim; H K Park; H J Na; J H Park
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

8.  Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.

Authors:  E M D L van der Heijden; J Chileshe; J C M Vernooij; C Gortazar; R A Juste; I Sevilla; J E Crafford; V P M G Rutten; A L Michel
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

9.  Intelectin 3 is dispensable for resistance against a mycobacterial infection in zebrafish (Danio rerio).

Authors:  Markus J T Ojanen; Meri I E Uusi-Mäkelä; Sanna-Kaisa E Harjula; Anni K Saralahti; Kaisa E Oksanen; Niklas Kähkönen; Juha A E Määttä; Vesa P Hytönen; Marko Pesu; Mika Rämet
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.